How health economics and outcomes research (HEOR) puts a value on steroid-toxicity A microsimulation model presented at ISPOR Europe 2025 put a number on the lifetime clinical and economic burden of ...
"Nothing in healthcare saves money. It is not quite true, but it is a good adage to keep in mind." Health economics has spent four decades asking whether the trillions spent on US healthcare are ...
A microsimulation model has quantified what clinicians have long suspected: sustained steroid exposure in autoimmune disease carries a measurable, and avoidable, clinical and economic burden that ...
Pharmaceutical companies need to replace dose reduction measures with direct toxicity measurement in health-economic models Dose reduction overlooks the hidden healthcare costs of steroid-toxicity. ...
“Steroids are cheap and effective in the short term. Convincing payers that steroid-sparing therapies are worth the upfront cost is still a practical challenge.” Albert Whangbo, PhD, leads the global ...